CTEXLI
Live / Registered — Registered (as of 30 Sept 2025)
What this means for you
Registered since 30 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98499814
- Registration number
- 7970726
- Mark type
- Stylized text
- Filed
- 15 Apr 2024
- Published for opposition
- 22 Oct 2024
- Registered
- 30 Sept 2025
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely, cerebrotendinous xanthomatosis (CTX)
Owner
- Mirum Pharmaceuticals, Inc., FOSTER CITY, CA, US
- Mirum Pharmaceuticals, Inc., FOSTER CITY, CA, US
- Mirum Pharmaceuticals, Inc., Foster City, CA, US
Prosecution history
- 30 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Jul 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Apr 2025 — USE AMENDMENT FILED
- 31 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION
- 02 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED